CRISPR Therapeutics AG
(CRSP)
undefined
undefined%
At close: undefined
43.85
0.23%
After-hours Dec 13, 2024, 07:08 PM EST
13F Institute Ownership
13F institutions, like mutual and pension funds, are large investors
required by the SEC to disclose their holdings quarterly, significantly
impacting company decisions and stock trends.
As of Sep 30, 2024,
442
Institutions hold a total of
59.45M CRISPR Therapeutics AG shares, with a combined investment of
$2.82B.
Others: 30.25%
Institutions: 69.75%
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 1.723
1.72
Call Flow 1,100,726
37%
Put Flow 1,896,100
63%
Top Shareholders
The Top 10 shareholders collectively own 22.98% of the CRISPR Therapeutics AG| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Capital International Investor... | 9.62% | 7.87M | +0.36% | 424.80M | 0.09% |
| Ark Investment Management LLC | 9.51% | 7.78M | -4.64% | 420.12M | 3.73% |
| Sumitomo Mitsui Trust Holdings... | 3.85% | 3.15M | -3.59% | 170.21M | 0.13% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.